A Randomized Study to Compare Effect of Endoscopic Injection of a Mixture of Cyanoacrylate and Lipiodol Versus Cyanoacrylate and Lauromacrogol in Gastric Varices
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 96
- 试验地点
- 1
- 主要终点
- bleeding rate of the puncture site
研究概览
简要总结
The purpose of this randomized study to compare effect of endoscopic injection of a mixture of cyanoacrylate and lipiodol versus cyanoacrylate and lauromacrogol in gastric varices.
详细描述
Gastroesophageal variceal bleeding is known as one of the most frequent death causes of patients with portal hypertension. When a patient has a bleeding episode, if no further prophylactic treatments is given, it's very likely that he/she will develop another rebleeding event in the future and maybe a terminal event. Gastric varices occur in 18-70% of patients with portal hypertension, which appear to be more severe, to require more transfusion and to have a higher mortality rate than esophageal variceal bleeding, with a high rate of rebleeding(38-89%). It has been recommended to use endoscopic cyanoacrylate injection as the first line treatment for hemostasis and secondary prophylaxis for gastric varices by general consensus. However, the efficacy and prevalence of complications between mixture of cyanoacrylate + lipiodol and cyanoacrylate + lauromacrogol have not yet been explored and reported. We conducted this study to evaluate the effect of endoscopic injection of a mixture of cyanoacrylate and lipiodol versus cyanoacrylate and lauromacrogol in gastric varices.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients presented to our hospital with acute gastric variceal bleeding, with or without liver cirrhosis.
- •The age of the patients range from 18 to 80 years old.
排除标准
- •Patients who have contraindications for cyanoacrylate, lipiodol or lauromacrogol therapy.
- •Patients who have abnormal portosystemic shunt according to the imaging results.
- •Patients who have no previous upper gastrointestinal bleeding history.
- •Patients who have multiple endoscopic treatments for esophagogastric varices before.
研究组 & 干预措施
NBCA-lipiodol
Patients will receive injection of a mixture of cyanoacrylate and lipiodol to treat gastric varices
干预措施: Lipiodol (Drug)
NBCA-lauromacrogol
Patients will receive injection of the mixture of cyanoacrylate and lauromacrogol to treat gastric varices
干预措施: Lauromacrogol (Drug)
结局指标
主要结局
bleeding rate of the puncture site
时间窗: time period since the beginning of the injection, until up to 24 hours after the procedure
We tend to observe the immediate puncture site bleed on the injection of cyanoacrylate and lipiodol or lauromacrogol and withdrawal of needle catheter during endoscopic treatment of gastric varices.
次要结局
- Rebleeding rate after endoscopic treatment(6 months from the date of enrollment)
研究者
Shiyao Chen
professor
Shanghai Zhongshan Hospital
